18 Despite the success of Vaccinia virus (VACV) against smallpox there remains a paucity of 19 information on Dendritic cell (DC) responses to the virus, especially on the traffic of DCs and 20 VACV to draining LN (dLN). Herein we studied skin DC migration in response to VACV and 21 compared it to the tuberculosis vaccine Mycobacterium bovis Bacille Calmette-Guérin (BCG), 22 another live-attenuated vaccine administered via the skin. In stark contrast to BCG, skin DCs 23 did not relocate to dLN in response to VACV. This happened in spite of virus-induced 24 accumulation of several other innate-immune cell populations in the dLN. UV inactivation of 25 VACV or use of the Modified Vaccinia virus Ankara (MVA) strain promoted DC movement 26 to dLN, indicating that the virus actively interferes with skin DC migration. This active immune 27 suppression by VACV was potent enough to ablate the mobilization of skin DCs in response to 28 BCG, and to reduce the transport of BCG to dLN. Expression of inflammatory mediators 29 associated with BCG-triggered DC migration were absent from virus-injected skin, suggesting 30 that other pathways provoke DC movement in response to replication-deficient VACV. Despite 31 viral suppression of DC migration, VACV was detected in dLN much earlier than BCG, 32 indicating a rapid, alternative route of viral traffic to dLN despite marked blockade of skin DC 33 mobilization from the site of infection. 34 35 Word count: 217 36 37